Shyam s bhartia - Latest News Update, Information, Photos & Videos on Shyam s bhartia at Lokmat Times

The share price of Jubilant Life Sciences surged 5 per cent hitting upper circuit of Rs 429.95 per share on Wednesday after the company signed a deal with US-based Gilead Sciences Inc for production of Remdesivir to fight COVID-19.Its subsidiary Jubilant Generics has entered into a non-exclusive licensing agreement with Gilead that will grant Jubilant the right to register, manufacture and sell Gilead's investigational drug Remdesivir, a potential therapy for Covid-19, in 127 countries including India.These countries consist of nearly all low-income and lower-middle-income countries as well as several upper-middle and high-income countries that face significant obstacles to healthcare access."We will be monitoring the clinical trials and regulatory approvals very closely and would be ready to launch the drug shortly after the required regulatory approvals," said Chairman Shyam S Bhartia and Co-Chairman & Managing Director Hari S Bhartia."We also plan to produce the drug's active pharmaceutical ingredient (API) in-house helping its cost-effectiveness and consistent availability," they said in a joint statement late on Tuesday.Under the licensing agreement, Jubilant will have the right to receive a technology transfer of the Gilead manufacturing process to scale up production to enable expedited access of the medicine to COVID-19 patients upon approvals by regulatory authorities in respective countries.Remdesivir, an investigational antiviral therapy developed by Gilead, has received emergency use authorisation (EUA) by the US Food and Drug Administration to treat COVID-19.( With inputs from ANI )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

Shyam S Bhartia, NewsFOLLOW

Shyam s bhartia, Latest News

Business :Jubilant Foodworks to bring Popeyes to India, Bangladesh, Nepal, Bhutan

Food services major Jubilant FoodWorks has entered into an exclusive master franchise and development agreement with PLK APAC Pte Ltd, a subsidiary of Restaurant Brands International Inc, to develop, establish, own and operate hundreds of Popeyes res ...

Business :Jubilant FoodWorks to acquire Fides Netherlands for 32.81 pc stake in DP Eurasia

Food services major Jubilant FoodWorks said on Friday it will fully acquire Fides Food Systems Cooperatief UA Netherlands (Fides) for an agreed investment of 24.8 million pounds (about Rs 250 crore) through its wholly-owned subsidiary Jubilant FoodWo ...

Business :Jubilant launches Remdesivir in India for treatment of COVID-19

Jubilant Life Sciences has launched Remdesivir for injection under the brand name JUBI-R in Indian market at a price of Rs 4,700 per vial of 100 mg and said it will make the drug available to over 1,000 hospitals providing COVID-19 treatment through ...

Business :Jubilant Life Sciences surges 5 pc after signing deal with Gilead for production of Remdesivir

The share price of Jubilant Life Sciences surged 5 per cent hitting upper circuit of Rs 429.95 per share on Wednesday after the company signed a deal with US-based Gilead Sciences Inc for production of Remdesivir to fight COVID-19. ...